|
KIF3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.67909999999805E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.224060E-04 |
| Normal-vs-Stage2 |
8.275800E-02 |
| Normal-vs-Stage3 |
1.008720E-04 |
| Normal-vs-Stage4 |
1.75030999999271E-05 |
| Stage1-vs-Stage2 |
4.778800E-01 |
| Stage1-vs-Stage3 |
2.255800E-01 |
| Stage1-vs-Stage4 |
1.763640E-01 |
| Stage2-vs-Stage3 |
1.545960E-01 |
| Stage2-vs-Stage4 |
1.475050E-01 |
| Stage3-vs-Stage4 |
9.210200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.202530E-04 |
| Normal-vs-AfricanAmerican |
1.09800000003268E-06 |
| Normal-vs-Asian |
2.206200E-01 |
| Caucasian-vs-AfricanAmerican |
5.325800E-02 |
| Caucasian-vs-Asian |
6.074400E-01 |
| AfricanAmerican-vs-Asian |
2.408600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.6343999999986E-05 |
| Normal-vs-Female |
1.963580E-04 |
| Male-vs-Female |
5.276800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.43330003421482E-09 |
| Normal-vs-Age(41-60Yrs) |
5.420700E-04 |
| Normal-vs-Age(61-80Yrs) |
9.60570000000383E-05 |
| Normal-vs-Age(81-100Yrs) |
3.668100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.85939999999674E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.204700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.822000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.826200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.222200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.470600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.346800E-01 |
| Normal-vs-Grade 2 |
1.541190E-03 |
| Normal-vs-Grade 3 |
3.50869999999892E-05 |
| Normal-vs-Grade 4 |
2.30590000427355E-08 |
| Grade 1-vs-Grade 2 |
7.085400E-01 |
| Grade 1-vs-Grade 3 |
3.946600E-01 |
| Grade 1-vs-Grade 4 |
3.031800E-02 |
| Grade 2-vs-Grade 3 |
3.804400E-01 |
| Grade 2-vs-Grade 4 |
1.476330E-03 |
| Grade 3-vs-Grade 4 |
9.756500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.487700E-02 |
| Normal-vs-ccB subtype |
2.69740000002905E-07 |
| ccA subtype-vs-ccB subtype |
3.72680000000347E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.762300E-04 |
| Normal-vs-N1 |
1.628190E-04 |
| N0-vs-N1 |
1.323850E-02 |
|
|
